Press release
Global Cancer Monoclonal Antibodies Market Growth, Size, Share, Industry Report and Forecast to 2026
The global cancer monoclonal antibodies market is estimated to grow at a CAGR of 9.8% during the forecast period. Significant research on monoclonal antibodies have been witnessed, which is providing a scope for the market growth. The availability of funding and the increasing focus of researchers and biopharmaceutical firms towards the development of monoclonal antibodies are some major factors driving the research on monoclonal antibodies. For instance, as per the Wellcome Trust, over 570 monoclonal antibodies are currently in clinical testing. In 2019, 7 of the 10 best-selling novel drugs were monoclonal antibodies for the treatment of cancer and inflammatory diseases.A full Report of Global Cancer Monoclonal Antibodies Market Available at https://www.omrglobal.com/industry-reports/cancer-monoclonal-antibodies-market
Additionally, the companies are collaborating for the development of novel monoclonal antibodies therapeutics for cancer. For instance, in April 2018, Boehringer Ingelheim and OSE Immunotherapeutics declared a partnership agreement for joint development of OSE-172. It is a monoclonal antibody targeting SIRP-alpha which is expressed in myeloid lineage cells. This antibody has the potential to increase anti-tumor immunity by increasing T cell activity through increasing the functionality of DC antigen presentation. The collaboration of OSE Therapeutics with Boehringer Ingelheim is its advanced approach for the treatment of cancer and will develop a new alliance to leverage the phase 1 development of OSE-172.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cancer-monoclonal-antibodies-market
Scope of the Global Cancer Monoclonal Antibodies Market
Market Coverage
• Market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and Application
• Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
• Competitive Landscape- Amgen Inc., Eli Lilly & Co., F. Hoffman-La Roche AG, Merck & Co., Inc., and Novartis AG
Recent Strategic Initiatives in the Global Cancer Monoclonal Antibodies Market
• In December 2019, Mylan N.V. and Biocon Ltd. declared the US FDA launch of Ogivri (trastuzumab-dkst). It is biosimilar to Herceptin (trastuzumab). It was the first biosimilar trastuzumab approved by the US FDA for all indications which includes treatment of HER2-overexpressing metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) and breast cancer.
• In June 2018, Pfizer Inc. announced the approval of ZIRABEV (bevacizumab-bvzr) in the US. It is a biosimilar to Avastin (bevacizumab) which is indicated to treat five kinds of cancer, including locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC), metastatic colorectal cancer, unresectable, metastatic renal cell carcinoma (RCC), recurrent glioblastoma; and persistent, recurrent or metastatic cervical cancer.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How COVID-19 impacted the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Cancer Monoclonal Antibodies Market-Segmentation
By Type
• Naked
• Conjugated
• Others (Bispecific)
By Application
• Breast Cancer
• Liver Cancer
• Blood Cancer
• Brain Cancer
• Colorectal Cancer
• Others
Global Cancer Monoclonal Antibodies Market– Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• The Middle East and Africa
Company Profiles
• AbbVie, Inc.
• Amgen, Inc.
• AstraZeneca plc
• Bayer AG
• Biocon, Ltd.
• Bristol Myers Squibb Co.
• Daiichi Sankyo Company, Ltd.
• Eli Lilly and Co.
• F. Hoffmann-La Roche AG
• Genmab A/S
• GlaxoSmithKline plc
• Innate Pharma S.A.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Mylan N.V.
• Novartis AG
• Oncologie, Inc.
• Pfizer Inc.
• Spectrum Pharmaceuticals, Inc.
• Takeda Pharmaceutical Co., Ltd.
For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/cancer-monoclonal-antibodies-market
For More Information, Visit https://www.omrglobal.com
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cancer Monoclonal Antibodies Market Growth, Size, Share, Industry Report and Forecast to 2026 here
News-ID: 2189411 • Views: …
More Releases from Orion Market Research

Used Cooking Oil Market Development, Industry Trends, Demand and Growth Analysis …
The global Used Cooking Oil (UCO) Market was valued at approximately USD 6.1 billion in 2023 and is projected to reach around USD 11.8 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of about 7.5% from 2024 to 2032.
Used Cooking Oil Market Overview
The Used Cooking Oil Market is gaining traction globally, driven by rising demand for sustainable biofuels, particularly biodiesel. Governments and environmental bodies are…

Loader Buckets Market to see Huge Growth by 2028
Market experts do detailed market study about entire market from several angles to depict the most updated and key market data to form this detailed Loader Buckets Market research report and help startups to reinforce their presence. This report further aims at covering vital data and figures on major areas such Asia Pacific, North America, Middle East, Europe, Latin America and Africa. Business participants can also obtain larger gains as…
Probiotics Supplement Market Trends, Business Overview, Industry Growth and Fore …
The global probiotics supplement market is anticipated to grow at a significant CAGR of 7.2% during the forecast period (2022-2028). The rising consumer awareness for healthcare and fitness with rising disposable income, are likely to drive the market growth. Probiotics enable to maintenance of a healthy balance of gut flora and have been linked to a variety of health advantages, including weight loss, digestive health, and immunological function. The market…
Brick Pavers Market Top Leading Players with Strategies and Forecast 2028
Brick Pavers Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Brick Pavers market with a focus on the market. The report provides key statistics on market of Brick Pavers. It is a valuable source of guidance and direction for companies and individuals interested in Brick Pavers industry.
Key Players
Belgard
Acme Brick Company
The Belden Brick Company
Wienerberger
Pine Hall Brick
Redland Brick
By Type
General Brick Pavers
Wall…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…